ATLAS ACS-TIMI 46 study group. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial - Mega, JL, I; Braunwald, E; Mohanavelu, S, I (Lancet, 2009)